Navigation Links
Treatment Algorithm Helps Successfully Manage Diabetes after Transplant Surgery
Date:4/16/2009

HOUSTON, April 16 /PRNewswire-USNewswire/ -- New research highlighting the relationship between steroids and insulin requirements suggests a possible treatment algorithm in post-liver transplant patients. This research will be presented on May 15, 2009 at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress in Houston, Texas.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b)

The tentative algorithm was developed as doctors tried to understand the elevation in blood sugar levels in patients that received post-operative steroids due to a liver transplant. The blood sugar rise was attributed to the toxic effects of steroid medications on beta cell function.

Additionally, the relationship between prolonged exposure to steroids generally six months revealed a strong relationship with persistent diabetes at a one year follow up after transplantation

"It appears that these steroids can lead to a permanent diabetic state," Umadevi Muthyala, M.D., said. "Prevention strategies must be considered in environments where they are commonly used."

Muthyala's team developed a tentative dosing algorithm to account for the increased insulin need in relation to steroid dosage.

"Although the data is not definitive, it gives us a handle on proper dosing and can be used to prospectively study other populations," she said.

Also at the 2009 AACE 18th Annual Meeting & Clinical Congress, diabetes experts will analyze the NICE-SUGAR study's impact on inpatient glycemic control. Other topics of interest include a look at the wide ranging impact of Vitamin D in the human body, and clinical recommendations for the treatment of prediabetes -- America's largest healthcare epidemic.

Media Registration

Media Registration for the AACE 18th Annual Meeting & Clinical Congress is available free of charge to members of the working media online here. Additional press releases concerning the meeting are available online here.

About AACE

AACE is a professional medical organization with more than 6,200 members in the United States and 92 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE initiatives inform the public about endocrine disorders. AACE also conducts continuing education programs for clinical endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine disease, such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity.

About the AACE Annual Meeting

The 18th Annual Meeting & Clinical Congress will be held in Houston, Texas on May 13-17 at the George R. Brown Convention Center, Hilton Americas Houston. The AACE Annual Meeting & Clinical Congress is structured to provide relevant clinical information for the practicing endocrinologist. The programs will focus on information that allows endocrinologists to achieve the best solutions for the diagnosis and management of endocrine diseases. Pertinent scientific, clinical practice and patient management will be disseminated via general sessions, workshops, meet-the-experts and satellite symposia.


'/>"/>
SOURCE American Association of Clinical Endocrinologists
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Dense Breasts Complicate Testing and Treatment
2. Medifocus Inc. Reports Improved Clinical Efficacy for its Phase II, Randomized Clinical Study for the Treatment of Early Stage Breast Cancer Tumors
3. Do patients at risk for B-cell malignancy need antiviral treatment?
4. Non-drug treatment of Alzheimers disease: Long-term benefit not proven
5. Ocean Cosmetic Medicine of Santa Monica Has Created Something New: Personalized Boutique Style Aesthetic Treatments
6. Melatonin is an effective treatment for sleep problems in children with autism
7. Mylan Confirms First-to-File Patent Challenge Relating to Xeloda(R) Cancer Treatment
8. Medarex to Receive Milestone Payment for Approval of SIMPONI(TM) for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
9. Singapore First in Southeast Asia to Use Novel Treatment for Sports and Musculoskeletal Injuries
10. Ex-White House Drug Czar McCaffrey, U.S. Congress Drug Caucus Chair Cummings, CRC Health CEO Karlin Join Hopkins Researchers at News Conference April 17 on Breakthrough Study: Internet Video Drug Treatment as Effective as Traditional Counseling
11. Blacks Less Likely to Get Optimal Lung Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Today, the Whole-Food Warrior TV show, ... much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian cuisine, will stream on ... week, on his weekly Whole-Food Warrior TV show, Frank Davis highlights Whole-Food Warriors - ...
(Date:2/5/2016)... New York, New York (PRWEB) , ... February 05, 2016 , ... ... your life? The answer may be at the tips of your toes. Foot massage, ... benefits as well as pure comfort and relaxation. The American Board of Multiple ...
(Date:2/5/2016)... ... February 05, 2016 , ... In the fourth quarter of ... at the La Valencia Hotel in San Diego, California to discuss changes in ... year’s most outstanding franchise, walking away with the coveted David Wright Award of ...
(Date:2/5/2016)... ... 2016 , ... Pivot Point Consulting, a leading national Healthcare ... Services for HIT Implementation Support & Staffing report with an outstanding score of ... healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. , ...
(Date:2/5/2016)... ... , ... Colorize is a web theme package created exclusively for ... Colorize's dynamic moving camera. Colorize is perfect for personal and web related videos and ... 1 to 5 focus points per scene, stage floor scene presets that are great ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Feb. 4, 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: ... has entered into a settlement agreement with the ... resolving the SEC,s investigation into possible violations of ... terms of the settlement agreement, SciClone has agreed ... disgorgement, pre-judgment interest and a penalty.  This payment ...
(Date:2/4/2016)... -- Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) ... Chronic Obstructive Pulmonary Disease (COPD) is a ... airways and lungs. Persistent breathing difficulties and repeated ... of the leading causes of morbidity and the ... is linked to cumulative exposure to risk factors, ...
(Date:2/4/2016)... ALBANY, N.Y. , Feb. 4, 2016  AMRI (NASDAQ: ... Vice President of Pfizer Inc. and President of Pfizer Global ... effective as of February 4, 2016. In addition, the Company ... member of the audit committee since 2010, has retired from ... time and attention to his other business ventures.  ...
Breaking Medicine Technology: